Statin Therapy May not Effect NLR and MPV Levels in Patients With Hypercholesterolemia: A Retrospective Study

Angiology
Fatih GungorenOsman Akin Serdar

Abstract

Statins may exert pleiotropic effects in coronary artery disease (CAD), diabetes mellitus, and familial hypercholesterolemia. We evaluated the effects of statins on the neutrophil-lymphocyte ratio (NLR) and mean platelet volume (MPV) in 261 consecutive patients with hypercholesterolemia having CAD or at high cardiovascular (CV) risk and 50 healthy participants who were retrospectively included in this study. Patients were treated with 10 to 80 mg atorvastatin or 10 to 40 mg rosuvastatin for 24 weeks according to baseline levels of cholesterol, triglycerides, and CV risk. Baseline NLR and MPV were significantly higher in patients with CAD or at high risk compared to the control group (1.89 [0.37-6.78]) vs 1.44 [0.75-2.41], P < .001 and 8.8 [6.27-18.6] vs 8.45 [6-11] fL, P = .038, respectively). The NLR, MPV, and lipid parameters were also compared in the patient group after statin treatment for 24 weeks. Lipid levels decreased but the NLR and MPV did not change significantly after the statin therapy. Further studies are needed to clarify the effect of statin therapy on NLR and MPV in patients with CAD or at high CV risk.

References

Jul 11, 1992·American Heart Journal·K Ensrud, R H Grimm
Feb 20, 1986·The New England Journal of Medicine·R Ross
Jun 1, 1995·Stroke; a Journal of Cerebral Circulation·T O'MalleyC Stewart
Jun 5, 1998·JAMA : the Journal of the American Medical Association·R S Rosenson, C C Tangney
Sep 17, 2003·Circulation·Scott KinlayUNKNOWN Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators
Jan 7, 2005·The New England Journal of Medicine·Paul M RidkerUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Inv
Nov 2, 2005·Journal of Thrombosis and Thrombolysis·Serkan CaySule Korkmaz
Dec 13, 2005·Nature Reviews. Drug Discovery·Mukesh K Jain, Paul M Ridker
Aug 31, 2006·Cardiovascular Drug Reviews·Kailash Prasad
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Aug 21, 2009·Journal of Thrombosis and Haemostasis : JTH·S G ChuJ S Berger
Sep 28, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Luigi Marzio BiasucciAntonella Stefanelli

❮ Previous
Next ❯

Citations

Mar 1, 2016·Nefrología : publicación oficial de la Sociedad Española Nefrologia·Diego Martínez-UrbistondoAna Huerta
Aug 19, 2020·European Journal of Clinical Investigation·Guoxia DongLei Liu
Dec 12, 2018·BioMed Research International·Teeranan AngkananardAmmarin Thakkinstian
Feb 6, 2021·Frontiers in Pharmacology·Alpo Vuorio, Petri T Kovanen

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.